Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1651 - 1675 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Ombitasvir/ paritaprevir/ ritonavir	cdr_SR0444_ombitasvir-paritaprevir-ritonavir.pdf SR0444_cdr_complete_Technivie_March-23-16_e.pdf SR0444_Technivie_CL_Report.pdf SR0444_Technivie_PE_Report.pdf SR0444 Technivie - PI_Submissions_Consolidated_validated.pdf	Aug 7, 2015	Reimbursement Review	Complete	SR0444-000
Xalkori Resubmission for First Line Advanced NSCLC - Details	pcodr-provfund_xalkori_nsclc1stline.pdf pcodr_xalkori_1stln_nsclc_fn_rec.pdf pcodr_xalkori_1stln_nsclc_fn_cgr.pdf pcodr_xalkori_1stln_nsclc_fn_egr.pdf pcodr_xalkori_1stln_nsclc_in_rec.pdf pcodr_xalkori_1stln_nsclc_pagfdk.pdf pcodr_xalkori_1stln_nsclc_fdk_pfizer.pdf pcodr_xalkori_1stln_nsclc_coi_ola.pdf pcodr_xalkori_1stln_nsclc_coi_lcc.pdf	Aug 6, 2015	Reimbursement Review	Complete	PC0054-000
Sacubitril/valsartan	cdr_SR0447_sacubitril_valsartan.pdf SR0447_complete_Entresto-Mar-22_e.pdf SR0447_Entresto_CL_Report.pdf SR0447_Entresto_PE_Report.pdf SR0447 Entresto Template_PI_Submissions_Consolidated_validated.pdf	Aug 4, 2015	Reimbursement Review	Complete	SR0447-000
Proleukin for In-transit Melanoma - Details	pcodr-provfund_proleukin-melanoma.pdf pcodr_aldesleukin_proleukin_fn_rec.pdf pcodr_adesleukin_proleukin_fn_cgr.pdf pcodr_adesleukin_proleukin_fn_egr.pdf pcodr-aldesleukin-proleukin-in-transit-melanoma-in-rec.pdf pcodr_adesleukin_proleukin_pagfdk_0.pdf pcodr_adesleukin_proleukin_fdk_novartis.pdf pcodr_adesleukin_proleukin_ptfdk_mnc.pdf pcodr_adesleukin_proleukin_coi_mnc.pdf pcodr_adesleukin_proleukin_coi_sysf.pdf	Jul 31, 2015	Reimbursement Review	Complete	PC0051-000
Xtandi First Line mCRPC - Details	pcodr-provfund_xtandi_mcrpc1stline.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fn_rec.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fn_cgr.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fn_egr.pdf pcodr_enzalutamide_xtandi_1stln_mcrcp_in_rec.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_pagfdk.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fdbk_astellas.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_ptfdk_pcc.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_coi_pcc.pdf	Jul 31, 2015	Reimbursement Review	Complete	PC0044-000
Asfotase alfa	cdr_SR0443_Strensiq.pdf SR0443_complete_Strensiq-Apr-4-16_e.pdf SR0443 Strensiq _PI_Submissions.pdf SR0443_Strensiq_CL_Report.pdf SR0443_Strensiq_PE_Report.pdf	Jul 20, 2015	Reimbursement Review	Complete	SR0443-000
Sylvant Multicentric Castleman's Disease - Details	pcodr_provfund_sylvant_mcd.pdf pcodr_siltuximab_sylvant_mcd_fn_rec.pdf pcodr_siltuximab_sylvant_mcd_fn_cgr.pdf pcodr_siltuximab_sylvant_mcd_fn_egr.pdf pcodr_siltuximab_sylvant_mcd_in_rec.pdf pcodr_siltuximab_sylvant_mcd_pagfdk.pdf pcodr_siltuximab_sylvant_mcd_fdk_janssen.pdf pcodr_siltuximab_sylvant_mcd_coi_cord.pdf	Jul 8, 2015	Reimbursement Review	Complete	PC0052-000
Sodium phenylbutyrate	SR0452 Pheburane.pdf SR0452_complete_Pheburane-Apr-25_16-e.pdf SR0452_Pheburane_CL_Report.pdf SR0452_Pheburane_PE_Report.pdf	Jul 6, 2015	Reimbursement Review	Complete	SR0452-000
Avastin for Ovarian Cancer - Details	pcodr_provfund_avastin-oc.pdf pcodr_bevacizumab_avastin_oc-fn_rec.pdf pcodr_bevacizumab_avastin_oc-fn_cgr.pdf pcodr_bevacizumab_avastin_oc-fn_egr.pdf pcodr_bevacizumab_avastin_oc_in_rec.pdf pcodr_bevacizumab_avastin_oc_pagfdk.pdf pcodr_bevacizumab_avastin_oc_fdk_hlroche.pdf pcodr_bevacizumab_avastin_oc_ptfdk_occ.pdf pcodr_bevacizumab_avastin_oc_coi_occ_0.pdf	Jun 26, 2015	Reimbursement Review	Complete	PC0047-000
Gazyva for Chronic Lymphocytic Leukemia - Details	pcodr-provfund_gazyva-cll.pdf pcodr-gazyva-cll-fn-rec.pdf pcodr-gazyva-cll-fn-cgr.pdf pcodr-gazyva-cll-fn-egr.pdf pcodr-gazyva-cll-in-rec.pdf pcodr-gazyva-cll-pagfdk.pdf pcodr-gazyva-cll-fdk-roche.pdf pcodr-gazyva-cll-fdk-lc.pdf pcodr-gazyva-cll-coi-lc.pdf pcodr-gazyva-cll-ptfdk.pdf pcodr-gazyva-cll-coi-llsc.pdf pcodr-gazyva-cll-coi-cllpag.pdf	Jun 26, 2015	Reimbursement Review	Complete	PC0041-000
Istodax for Peripheral T-Cell Lymphoma - Details	pcodr_provfund_istodax_ptcl.pdf pcodr_romidepsin_istodax_ptcl_fn_rec.pdf pcodr_romidepsin_istodax_ptcl_fn_cgr.pdf pcodr_romidepsin_istodax_ptcl_fn_egr.pdf pcodr_romidepsin_istodax_ptcl_in_rec.pdf pcodr_romidepsin_istodax_ptcl_pagfdk.pdf pcodr_romidepsin_istodax_ptcl_fdk_celgene.pdf	Jun 26, 2015	Reimbursement Review	Complete	PC0048-000
Evolocumab	cdr_SR0441_Repatha.pdf SR0441_complete_Rapatha-Feb-23_16_e.pdf SR0441_Repatha_CL_Report.pdf SR0441_Repatha_PE_Report.pdf SR0441_Repatha_PI_Submissions.pdf	Jun 4, 2015	Reimbursement Review	Complete	SR0441-000
Bosulif for Chronic Myeloid Leukemia - Details	pcodr_profund_boustinib_bosulif_cml.pdf pcodr_bosutinib_bosulif_cml_fn_rec.pdf pcodr_bosutinib_bosulif_cml_fn_cgr.pdf pcodr_bosutinib_bosulif_cml_fn_egr.pdf pcodr_bosutinib_bosulif_cml_in_rec.pdf pcodr_bosutinib_bosulif_cml_pagfdk.pdf pcodr_bosutinib_bosulif_cml_fdk_pfizer.pdf pcodr_bosutinib_bosulif_cml_coi_cmlsc.pdf	Jun 4, 2015	Reimbursement Review	Complete	PC0039-000
Fluticasone furoate	cdr_SR0439_fluticasone_furoate.pdf SR0439_complete_Arnuity-Ellipta-Dec-21-15_e.pdf SR0439_Arnuity_Ellipta_CL_Report.pdf SR0439_Arnuity_Ellipta_PE_Report.pdf SR0439_Arnuity_Ellipta_PI_Submissions.pdf	May 4, 2015	Reimbursement Review	Complete	SR0439-000
Galsulfase (Drug Plan Submission)	cdr_SR0434_Naglazyme.pdf SR0434_complete_Naglazyme-Feb-23_16_e.pdf SR0434_Naglazyme_CL_Report.pdf SR0434_Naglazyme_PE_Report.pdf SR0434_Naglazyme_PI_Submissions.pdf	Apr 27, 2015	Reimbursement Review	Complete	SR0434-000
Rotigotine	cdr_SR0432_Neupro_Resubmission.pdf SR0432_complete_Neupro_Resb_Nov-24-15_e.pdf SR0432_Neupro_CL_Report_resub.pdf SR0432_Neupro_PE_Report_resub.pdf SR0432_Neupro_PI_Submissions.pdf	Apr 23, 2015	Reimbursement Review	Complete	SR0432-000
Pruning Emtree: Does Focusing Embase Subject Headings Impact Search Strategy Precision and Sensitivity?	ATS0022_Pruning Emtree_Methods_Project_e.pdf	Apr 16, 2015	Health Technology Review
Avastin for Cervical Cancer - Details	pcodr_provfund_avastin-cc.pdf pcodr-avastincc-fn-rec.pdf pcodr-avastin-cc-fn-cgr.pdf pcodr-avastin-cc-fn-egr.pdf pcodr-avastin-cc-in-rec.pdf pcodr-avastincc-pagfdk.pdf pcodr-avastincc-fdk-hlr.pdf pcodr-avastincc-fdk-occ.pdf pcodr-avastincc-coi-occ.pdf	Apr 8, 2015	Reimbursement Review	Complete	PC0045-000
Ivacaftor	cdr_SR0430_Kalydeco_R117H.pdf SR0430_complete_Kalydeco_R117H_Nov-23-15_e.pdf SR0430_KalydecoR117H_CL_Report.pdf SR0430_KalydecoR117H_PE_Report.pdf SR0430_KalydecoR117H_PI_Submissions.pdf	Apr 1, 2015	Reimbursement Review	Complete	SR0430-000
Apremilast	cdr_SR0437_Otezla_PsA.pdf SR0437_complete_Otezla_PsA-Dec-21-15_e.pdf SR0437_OtezlaPsA_CL_Report.pdf SR0437_OtezlaPsA_PE_Report.pdf SR0437_OtezlaPsA_PI_Submissions.pdf	Mar 31, 2015	Reimbursement Review	Complete	SR0437-000
Ivermectin	SR0429 Rosiver.pdf SR0429_complete_Rosiver_Nov-23-15_e.pdf SR0429_Rosiver_CL_Report.pdf SR0429_Rosiver_PE_Report.pdf SR0429 Rosiver_PI_Submissions_Consolidated_validated.pdf	Mar 30, 2015	Reimbursement Review	Complete	SR0429-000
Imbruvica for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (previously treated) - Details	pcodr-provfund_ibrutinib_imbruvica-CLL.pdf pcodr-ibrutinib-cll-sll-fn-rec.pdf pcodr-ibrutinib-cll-sll-fn-cgr.pdf pcodr-ibrutinib-cll-sll-fn-egr.pdf pcodr-ibrutinib-cll-sll-in-rec.pdf pcodr-ibrutinib-pagfdk.pdf pcodr-ibrutinib-fdk-janssen.pdf pcodr-ibrutinib-fdk-llsccllpag.pdf pcodr-ibrutinib-coi-llsc.pdf pcodr-ibrutinib-coi-cllpag.pdf pcodr-ibrutinib-cll-sll-fdk-lc.pdf pcodr-ibrutinib-cll-sll-coi-lc.pdf	Mar 20, 2015	Reimbursement Review	Complete	PC0043-000
Drugs for Pulmonary Arterial Hypertension	TR0006-PAH-InBrief-e.pdf TR0006_PAH_Protocol_e.pdf TR0006_PAH_ScienceReport.pdf TR0006_PAH_Recs_Report.pdf	Mar 16, 2015	Health Technology Review		TR0006-000
Nintedanib	cdr_SR0426_Ofev.pdf SR0426_Ofev_Oct-19-15.pdf SR0426_Ofev_CL_Report.pdf SR0426_Ofev_PE_Report.pdf SR0426_Ofev_PI_Submissions.pdf	Mar 13, 2015	Reimbursement Review	Complete	SR0426-000
Denosumab (Drug Plan Submission)	cdr_SR0414_Prolia-Men.pdf SR0414_cdr_complete_Prolia-Men_Sept-21-15-e.pdf SR0414_ProliaMen_CL_Report.pdf SR0414_ProliaMen_PE_Report.pdf SR0414_ProliaMen_PI_Submissions.pdf	Mar 10, 2015	Reimbursement Review	Complete	SR0414-000